Ankri, C.; Hershkovitz, O.; Hershkovitz, L.; Brami, M.; Levy, R.; Sarig, H.; Souli, E.; Reicher, B.; Amor-Baroukh, V.; Mevorach, D.;
et al. Safety of Repeated Administration of Xenogeneic Human Apoptotic State (Allocetra-OTS) in Sprague Dawley Rats. Pharmaceutics 2024, 16, 426.
https://doi.org/10.3390/pharmaceutics16030426
AMA Style
Ankri C, Hershkovitz O, Hershkovitz L, Brami M, Levy R, Sarig H, Souli E, Reicher B, Amor-Baroukh V, Mevorach D,
et al. Safety of Repeated Administration of Xenogeneic Human Apoptotic State (Allocetra-OTS) in Sprague Dawley Rats. Pharmaceutics. 2024; 16(3):426.
https://doi.org/10.3390/pharmaceutics16030426
Chicago/Turabian Style
Ankri, Chen, Oren Hershkovitz, Liat Hershkovitz, Meital Brami, Ronnie Levy, Hadar Sarig, Einat Souli, Barak Reicher, Veronique Amor-Baroukh, Dror Mevorach,
and et al. 2024. "Safety of Repeated Administration of Xenogeneic Human Apoptotic State (Allocetra-OTS) in Sprague Dawley Rats" Pharmaceutics 16, no. 3: 426.
https://doi.org/10.3390/pharmaceutics16030426
APA Style
Ankri, C., Hershkovitz, O., Hershkovitz, L., Brami, M., Levy, R., Sarig, H., Souli, E., Reicher, B., Amor-Baroukh, V., Mevorach, D., & Nyska, A.
(2024). Safety of Repeated Administration of Xenogeneic Human Apoptotic State (Allocetra-OTS) in Sprague Dawley Rats. Pharmaceutics, 16(3), 426.
https://doi.org/10.3390/pharmaceutics16030426
